J. Virol., 09 1996, 5909-5915, Vol 70, No. 9
Copyright © 1996, American Society for Microbiology

Epstein-Barr virus EBNA3A and EBNA3C proteins both repress RBP-J kappa- EBNA2-activated transcription by inhibiting the binding of RBP-J kappa to DNA

L Waltzer, M Perricaudet, A Sergeant and E Manet
Unite de Virologie Humaine, U412 INSERM, Ecole Normale Superieure de Lyon, France.

Following infection by Epstein-Barr virus (EBV), the production of viral nuclear proteins EBNA1, EBNA2, EBNA3A, and EBNA3C and the viral membrane protein LMP1 is essential for the permanent proliferation of primary B lymphocytes to occur. Among these, the transcription factor EBNA2 is central to the immortalizing process, since it activates not only the transcription of all the EBNA proteins and LMP1, TP1, and TP2 but also certain cellular genes. EBNA2 is targeted to its DNA- responsive elements through direct interaction with the DNA-binding cellular repressor RBP-J kappa. In a transient-expression assay, the EBNA2-activated transcription was found to be downregulated by EBNA3A, EBNA3B, and EBNA3C. However, since it has been reported that EBNA3C, but not EBNA3A, directly contacts RBP-J kappa in vitro, these proteins appear to repress through different mechanisms. Here, we report for the first time that EBNA3A and EBNA3C both stably interact with RBP-J kappa and most probably repress EBNA2-activated transcription by destabilizing the binding of RBP-J kappa to DNA.

This article has been cited by other articles:

• Maruo, S., Wu, Y., Ishikawa, S., Kanda, T., Iwakiri, D., Takada, K. (2006). Epstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 103: 19500-19505 [Abstract] [Full Text]  
• Portal, D., Rosendorff, A., Kieff, E. (2006). Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4. Proc. Natl. Acad. Sci. USA 103: 19278-19283 [Abstract] [Full Text]  
• Jimenez-Ramirez, C., Brooks, A. J., Forshell, L. P., Yakimchuk, K., Zhao, B., Fulgham, T. Z., Sample, C. E. (2006). Epstein-Barr Virus EBNA-3C Is Targeted to and Regulates Expression from the Bidirectional LMP-1/2B Promoter. J. Virol. 80: 11200-11208 [Abstract] [Full Text]  
• Kelly, G. L., Milner, A. E., Baldwin, G. S., Bell, A. I., Rickinson, A. B. (2006). Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. Proc. Natl. Acad. Sci. USA 103: 14935-14940 [Abstract] [Full Text]  
• Hiriart, E., Gruffat, H., Buisson, M., Mikaelian, I., Keppler, S., Meresse, P., Mercher, T., Bernard, O. A., Sergeant, A., Manet, E. (2005). Interaction of the Epstein-Barr Virus mRNA Export Factor EB2 with Human Spen Proteins SHARP, OTT1, and a Novel Member of the Family, OTT3, Links Spen Proteins with Splicing Regulation and mRNA Export. J. Biol. Chem. 280: 36935-36945 [Abstract] [Full Text]  
• Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Zhao, B., Kieff, E. (2005). Epstein-Barr Virus Nuclear Protein 3A Domains Essential for Growth of Lymphoblasts: Transcriptional Regulation through RBP-J{kappa}/CBF1 Is Critical. J. Virol. 79: 10171-10179 [Abstract] [Full Text]  
• Touitou, R., O'Nions, J., Heaney, J., Allday, M. J. (2005). Epstein-Barr virus EBNA3 proteins bind to the C8/{alpha}7 subunit of the 20S proteasome and are degraded by 20S proteasomes in vitro, but are very stable in latently infected B cells. J. Gen. Virol. 86: 1269-1277 [Abstract] [Full Text]  
• Peng, R., Moses, S. C., Tan, J., Kremmer, E., Ling, P. D. (2005). The Epstein-Barr Virus EBNA-LP Protein Preferentially Coactivates EBNA2-Mediated Stimulation of Latent Membrane Proteins Expressed from the Viral Divergent Promoter. J. Virol. 79: 4492-4505 [Abstract] [Full Text]  
• West, M. J., Webb, H. M., Sinclair, A. J., Woolfson, D. N. (2004). Biophysical and Mutational Analysis of the Putative bZIP Domain of Epstein-Barr Virus EBNA 3C. J. Virol. 78: 9431-9445 [Abstract] [Full Text]  
• Thompson, M. P., Kurzrock, R. (2004). Epstein-Barr Virus and Cancer. Clin. Cancer Res. 10: 803-821 [Abstract] [Full Text]  
• Rosendorff, A., Illanes, D., David, G., Lin, J., Kieff, E., Johannsen, E. (2004). EBNA3C Coactivation with EBNA2 Requires a SUMO Homology Domain. J. Virol. 78: 367-377 [Abstract] [Full Text]  
• Maruo, S., Johannsen, E., Illanes, D., Cooper, A., Kieff, E. (2003). Epstein-Barr Virus Nuclear Protein EBNA3A Is Critical for Maintaining Lymphoblastoid Cell Line Growth. J. Virol. 77: 10437-10447 [Abstract] [Full Text]  
• Liang, Y., Ganem, D. (2003). Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling. Proc. Natl. Acad. Sci. USA 100: 8490-8495 [Abstract] [Full Text]  
• Zhao, B., Dalbies-Tran, R., Jiang, H., Ruf, I. K., Sample, J. T., Wang, F., Sample, C. E. (2003). Transcriptional Regulatory Properties of Epstein-Barr Virus Nuclear Antigen 3C Are Conserved in Simian Lymphocryptoviruses. J. Virol. 77: 5639-5648 [Abstract] [Full Text]  
• Cooper, A., Johannsen, E., Maruo, S., Cahir-McFarland, E., Illanes, D., Davidson, D., Kieff, E. (2002). EBNA3A Association with RBP-J{kappa} Down-Regulates c-myc and Epstein-Barr Virus-Transformed Lymphoblast Growth. J. Virol. 77: 999-1010 [Abstract] [Full Text]  
• Hickabottom, M., Parker, G. A., Freemont, P., Crook, T., Allday, M. J. (2002). Two Nonconsensus Sites in the Epstein-Barr Virus Oncoprotein EBNA3A Cooperate to Bind the Co-repressor Carboxyl-terminal-binding Protein (CtBP). J. Biol. Chem. 277: 47197-47204 [Abstract] [Full Text]  
• Rivailler, P., Cho, Y.-g., Wang, F. (2002). Complete Genomic Sequence of an Epstein-Barr Virus-Related Herpesvirus Naturally Infecting a New World Primate: a Defining Point in the Evolution of Oncogenic Lymphocryptoviruses. J. Virol. 76: 12055-12068 [Abstract] [Full Text]  
• Liang, Y., Chang, J., Lynch, S. J., Lukac, D. M., Ganem, D. (2002). The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev. 16: 1977-1989 [Abstract] [Full Text]  
• Lin, J., Johannsen, E., Robertson, E., Kieff, E. (2002). Epstein-Barr Virus Nuclear Antigen 3C Putative Repression Domain Mediates Coactivation of the LMP1 Promoter with EBNA-2. J. Virol. 76: 232-242 [Abstract] [Full Text]  
• Touitou, R., Hickabottom, M., Parker, G., Crook, T., Allday, M. J. (2001). Physical and Functional Interactions between the Corepressor CtBP and the Epstein-Barr Virus Nuclear Antigen EBNA3C. J. Virol. 75: 7749-7755 [Abstract] [Full Text]  
• Zhang, J., Chen, H., Weinmaster, G., Hayward, S. D. (2001). Epstein-Barr Virus BamHI-A Rightward Transcript-Encoded RPMS Protein Interacts with the CBF1-Associated Corepressor CIR To Negatively Regulate the Activity of EBNA2 and NotchIC. J. Virol. 75: 2946-2956 [Abstract] [Full Text]  
• Dalbiès-Tran, R., Stigger-Rosser, E., Dotson, T., Sample, C. E. (2001). Amino Acids of Epstein-Barr Virus Nuclear Antigen 3A Essential for Repression of J{kappa}-Mediated Transcription and Their Evolutionary Conservation. J. Virol. 75: 90-99 [Abstract] [Full Text]  
• Wu, D. Y., Krumm, A., Schubach, W. H. (2000). Promoter-Specific Targeting of Human SWI-SNF Complex by Epstein-Barr Virus Nuclear Protein 2. J. Virol. 74: 8893-8903 [Abstract] [Full Text]  
• Nicholas, J (2000). Evolutionary aspects of oncogenic herpesviruses. Mol. Pathol. 53: 222-237 [Abstract] [Full Text]  
• Zhao, B., Sample, C. E. (2000). Epstein-Barr Virus Nuclear Antigen 3C Activates the Latent Membrane Protein 1 Promoter in the Presence of Epstein-Barr Virus Nuclear Antigen 2 through Sequences Encompassing an Spi-1/Spi-B Binding Site. J. Virol. 74: 5151-5160 [Abstract] [Full Text]  
• Zhou, S., Fujimuro, M., Hsieh, J. J.-D., Chen, L., Hayward, S. D. (2000). A Role for SKIP in EBNA2 Activation of CBF1-Repressed Promoters. J. Virol. 74: 1939-1947 [Abstract] [Full Text]  
• Grundhoff, A. T., Kremmer, E., Tureci, O., Glieden, A., Gindorf, C., Atz, J., Mueller-Lantzsch, N., Schubach, W. H., Grasser, F. A. (1999). Characterization of DP103, a Novel DEAD Box Protein That Binds to the Epstein-Barr Virus Nuclear Proteins EBNA2 and EBNA3C. J. Biol. Chem. 274: 19136-19144 [Abstract] [Full Text]  
• Radkov, S. A., Touitou, R., Brehm, A., Rowe, M., West, M., Kouzarides, T., Allday, M. J. (1999). Epstein-Barr Virus Nuclear Antigen 3C Interacts with Histone Deacetylase To Repress Transcription. J. Virol. 73: 5688-5697 [Abstract] [Full Text]  
• Kienzle, N., Young, D. B., Liaskou, D., Buck, M., Greco, S., Sculley, T. B. (1999). Intron Retention May Regulate Expression of Epstein-Barr Virus Nuclear Antigen 3 Family Genes. J. Virol. 73: 1195-1204 [Abstract] [Full Text]  
• Rouault, J.-P., Prevot, D., Berthet, C., Birot, A.-M., Billaud, M., Magaud, J.-P., Corbo, L. (1998). Interaction of BTG1 and p53-regulated BTG2 Gene Products with mCaf1, the Murine Homolog of a Component of the Yeast CCR4 Transcriptional Regulatory Complex. J. Biol. Chem. 273: 22563-22569 [Abstract] [Full Text]  
• Cludts, I., Farrell, P. J. (1998). Multiple Functions within the Epstein-Barr Virus EBNA-3A Protein. J. Virol. 72: 1862-1869 [Abstract] [Full Text]  
• Bourillot, P., Waltzer, L, Sergeant, A, Manet, E (1998). Transcriptional repression by the Epstein-Barr virus EBNA3A protein tethered to DNA does not require RBP-Jkappa. J. Gen. Virol. 79: 363-370 [Abstract]  
• Fuentes-Panana, E. M., Ling, P. D. (1998). Characterization of the CBF2 Binding Site within the Epstein-Barr Virus Latency C Promoter and Its Role in Modulating EBNA2-Mediated Transactivation. J. Virol. 72: 693-700 [Abstract] [Full Text]  
• Cahir-McFarland, E. D., Davidson, D. M., Schauer, S. L., Duong, J., Kieff, E. (2000). NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 97: 6055-6060 [Abstract] [Full Text]